![Steven Hughes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Steven G.
Hughes is Chief Development Officer at Arcturus Therapeutics, Inc. since 2020 and Chief Medical Officer at Atrium Therapeutics, Inc. Former roles include Medical Director-UK & Ireland at Biogen Idec Ltd., Chief Clinical Development Officer at Ionis Pharmaceuticals, Inc., Chief Medical Officer at VivoSim Labs, Inc. from 2018 to 2019, Chief Development Officer at Arcturus Therapeutics Holdings, Inc., and Chief Medical Officer at Avidity Biosciences, Inc. from 2022 to 2026.
Education includes a doctorate from Imperial College London and an MBA from Imperial College Business School.
Steven Hughes active positions
| Companies | Position | Start |
|---|---|---|
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Corporate Officer/Principal | 02/01/2020 |
Former positions of Steven Hughes
| Companies | Position | End |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 27/02/2026 |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Chief Tech/Sci/R&D Officer | 14/02/2022 |
| VIVOSIM LABS, INC. | Chief Tech/Sci/R&D Officer | 01/08/2019 |
Biogen Idec Ltd.
 Biogen Idec Ltd. BiotechnologyHealth Technology Develops therapies for neurodegenerative, haematologic, and autoimmune disorders | Corporate Officer/Principal | - |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Steven Hughes
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
VivoSim Labs, Inc.
 VivoSim Labs, Inc. BiotechnologyHealth Technology Engages in developing and commercializing functional human tissues | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Avidity Biosciences, Inc.
 Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec Ltd.
Biogen Idec Ltd. BiotechnologyHealth Technology Develops therapies for neurodegenerative, haematologic, and autoimmune disorders | Health Technology |
Imperial College Business School
 Imperial College Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcturus Therapeutics Holdings, Inc.
 Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Steven Hughes
